Concepedia

Author

Nihel Khoudour

Assistance Publique – Hôpitaux de ParisORCID

Also Known As

Isabelle Meyts, Khoudour, N., N. Khoudour, Nihel Khoudour

38

Publications

876

Citations

17

H-Index

32

Concepts

All Affiliations

Assistance Publique – Hôpitaux de ParisInsermUniversité Paris CitéHôpital CochinCentre National de la Recherche Scientifique
NK

About

Nihel Khoudour is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

234

2

Biochemistry

2

2

88

3

Immunology

2

2

82

4

Medical Laboratory Science

1

1

40

5

Microbiology

1

1

74

Nihel Khoudour

×

18

Publications

561

Citations

16

H-Index

YearCitations

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur,

Cancers

2020

110

Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection

Tiphaine Legrand, Dominique Vodovar, Nicolas Tournier,

Antimicrobial Agents and Chemotherapy

2016

74

Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC–MS/MS

Marie Allard, Nihel Khoudour, Benoı̂t Rousseau,

Journal of Pharmaceutical and Biomedical Analysis

2017

42

Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA

Aurélien Millet, Nihel Khoudour, Pauline Bros,

Talanta

2020

40

Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?

Audrey Bellesœur, Édouard Ollier, Marie Allard,

Cancers

2019

31

Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study

Luigi Cerbone, David Combarel, Arthur Géraud,

ESMO Open

2021

31

Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study

Clémence Marin, Nihel Khoudour, Aurélien Millet,

Pharmaceuticals

2021

27

Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

Thomas Rodier, Alicja Puszkiel, Evelina Cardoso,

Pharmaceutics

2022

27

Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma

David Balakirouchenane, Sarah Guégan, Chantal Csajka,

Cancers

2020

26

Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study

Maud Velev, Alicja Puszkiel, Benoı̂t Blanchet,

Pharmaceuticals

2021

22

Page 1